About 80% of patients with NSCLC overexpress epidermal growth factor receptor (EGFR).[13] Its overexpression has an important effect on tumor cell growth, proliferation, metastasis, and angiogenesis and is closely related to the prognosis and survival rate of resected tumor patients. Here, EGFR is linked to non-small cell lung carcinoma.